ArticleCancers2024
Regorafenib Combined with BRAF/MEK Inhibitors for the Treatment of Refractory Melanoma Brain Metastases.
Iris Dirven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
ArticleCancers2024
Iris Dirven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.